Reduction of platelet adhesiveness in patients with coronary artery disease.
D000328:Adult; D001792:Blood Platelets / Q000187:drug effects*; D001797:Blood Protein Electrophoresis; D001809:Blood Viscosity / Q000187:drug effects*; D050260:Carbohydrate Metabolism; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000188:drug therapy*; D004176:Dipyridamole / Q000627:therapeutic use*; D005951:Glucose Tolerance Test; D006801:Humans; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
D008074:Lipoproteins; D014280:Triglycerides; D004176:Dipyridamole; D002784:Cholesterol